These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10217207)

  • 1. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines.
    Sato M; Iwakabe K; Kimura S; Nishimura T
    Immunol Lett; 1999 Mar; 67(1):63-8. PubMed ID: 10217207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes.
    Sato M; Iwakabe K; Ohta A; Sekimoto M; Nakui M; Koda T; Kimura S; Nishimura T
    Int Immunol; 2000 Mar; 12(3):335-42. PubMed ID: 10700468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients.
    Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Takita K; Sekikawa K; Takenoshita S; Ogata T; Ohto H
    Anticancer Res; 2005; 25(1B):443-9. PubMed ID: 15816609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
    Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE
    Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
    Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
    Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2).
    Hata M; Takahara S; Tsuzaki H; Ishii Y; Nakata K; Akagawa KS; Satoh K
    Immunol Lett; 2009 Sep; 126(1-2):29-36. PubMed ID: 19643136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
    Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
    J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells.
    Klangsinsirikul P; Russell NH
    Exp Hematol; 2002 May; 30(5):495-501. PubMed ID: 12031657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.
    Li Y; Chu N; Rostami A; Zhang GX
    J Immunol; 2006 Aug; 177(3):1679-88. PubMed ID: 16849477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal control of T helper cell and dendritic cell differentiation.
    Rissoan MC; Soumelis V; Kadowaki N; Grouard G; Briere F; de Waal Malefyt R; Liu YJ
    Science; 1999 Feb; 283(5405):1183-6. PubMed ID: 10024247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells.
    Whelan M; Harnett MM; Houston KM; Patel V; Harnett W; Rigley KP
    J Immunol; 2000 Jun; 164(12):6453-60. PubMed ID: 10843701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.
    Ria F; Penna G; Adorini L
    Eur J Immunol; 1998 Jun; 28(6):2003-16. PubMed ID: 9645382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells.
    Aloisi F; De Simone R; Columba-Cabezas S; Penna G; Adorini L
    J Immunol; 2000 Feb; 164(4):1705-12. PubMed ID: 10657614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity.
    Imazeki I; Matsuzaki J; Tsuji K; Nishimura T
    Biomed Res; 2006 Feb; 27(1):1-9. PubMed ID: 16543659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development.
    Skok J; Poudrier J; Gray D
    J Immunol; 1999 Oct; 163(8):4284-91. PubMed ID: 10510367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation.
    Chang CC; Wright A; Punnonen J
    J Immunol; 2000 Oct; 165(7):3584-91. PubMed ID: 11034359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.
    Khanna A; Morelli AE; Zhong C; Takayama T; Lu L; Thomson AW
    J Immunol; 2000 Feb; 164(3):1346-54. PubMed ID: 10640749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.
    Kiertscher SM; Gitlitz BJ; Figlin RA; Roth MD
    Int J Cancer; 2003 Nov; 107(2):256-61. PubMed ID: 12949803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.